Tag: Illumina
Illumina corrects on Wall Street
By Jean-Noël Legalland Published on 02/09/2024 at 2:25 p.m. Photo credit © UzirePictures (Boursier.com) — Illumina is losing…
Illumina disappoints in its 2024 revenue outlook
(AOF) – Illumina is expected to fall in the pre-market on Wall Street after having announced that it expects 2024 turnover to be approximately equal to that of 2023. The…
Illumina expected to rise after announcement of Grail sale – 12/18/2023 at 1:23 p.m.
(AOF) – Illumina is expected to rise sharply in the pre-market on Wall Street after announcing its decision to sell the company Grail, in accordance with the sale order of…
Illumina willing to sell Grail if its appeal to the CJEU fails
(AOF) – Illumina announced on Friday that it would sell the cancer screening test manufacturer Grail in 12 months, under the terms of the European Commission’s order, in the event…
Brussels orders Illumina to sell Grail
End of the wedding for Illumina and Grail. On Thursday October 12, the European Commission ordered the global DNA sequencing giant to sell the biotech specializing in the development of…
Illumina: semi-victory for activist investor Carl Icahn – 05/26/2023 at 15:04
Illumina is expected to break even on Wall Street after activist investor Carl Icahn’s half-victory yesterday: if he failed to topple the gene sequencing giant’s CEO in battle of proxies…
Illumina: good visibility?
Through Jean-Noel Legalland Published on 01/10/2023 at 10:06 Photo credit © PivèsPictures (Boursier.com)…
EU vetoes takeover of GRAIL by Illumina
Published on 09/06/2022 at 1:49 p.m. BRUSSELS, Sept 6 (Reuters) – The European Commission (EC) on Tuesday vetoed the acquisition of GRAIL, a…
EU vetoes takeover of GRAIL by Illumina
Published on 09/06/2022 at 2:16 p.m. Photo credit © Reuters BRUSSELS (Reuters)…
Illumina will appeal, following the European decision on Grail
By Jean-Noel Legalland Published on 09/06/2022 at 2:20 p.m. Photo credit © Reuters …
Brussels vetoes the takeover of Grail by Illumina
This is a setback for the global DNA sequencing giant. The European Commission announced on Tuesday, September 6, to veto the merger of the American Illumina with its compatriot Grail,…
Illumina: results below expectations – 08/12/2022 at 14:48
(AOF) – The action of the Illumina genetic sequencing laboratory fell by nearly 15% in pre-market after quarterly results deemed disappointing and below forecasts. The group reported a loss of…